VTRLY 股價走勢圖
VTRLY 收益
Vitrolife AB
$11
0%
$0
收盤價：May 08, 16:00:00 GMT-4
$11
0%
$0
盤後：May 08, 20:00:00 GMT-4
返回
Vitrolife AB (VTRLY) 收益
關鍵數據
前收市價
$11
開盤價
$11
當日範圍
$11 - $11
52週區間
$9.5 - $18.54
交易量
130
平均成交量
249
股息收益率
--
每股盈餘 (TTM)
-3.93
市值
$1.4B
什麼是 Vitrolife AB？
Vitrolife AB develops, produces, and markets products for creating, prolonging, and improving life. The company is headquartered in Goeteborg, Vastra Gotalands and currently employs 1,151 full-time employees. The company went IPO on 2001-06-26. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. The company also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The firm is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.
